January 15, 2026
Breakthrough T1D Awards $1.5 Million Grant to Blue Circle Health to Expand Access to Care for Underserved Adults with Type 1 Diabetes
January 12, 2026
Breakthrough T1D Celebrates Tezeild Approval in the EU
January 12, 2026
Invictus Therapeutics and Breakthrough T1D Announce Collaboration to Support First-in-Human Trial of Next-Generation Insulin Analog
December 10, 2025
Breakthrough T1D-Led Paper Outlines First International Consensus Guidance for Continuous Ketone Monitoring in Diabetes
December 10, 2025
Syntax Bio Receives Award from Breakthrough T1D to Advance Pancreatic Beta Cell Therapy for Type 1 Diabetes
November 17, 2025
Pluristyx Collaborates with Breakthrough T1D to Make “Immune-Cloaked” and Safety Switch-Enabled Allogeneic Cell Line for Type 1 Diabetes Therapies
November 14, 2025
New Global Alliance ALIGN-T1D Commits to Transforming Diabetes Care in Low- and Middle-Income Countries
November 13, 2025
Breakthrough T1D Honors World Diabetes Day with “The State of T1D”
November 13, 2025
Breakthrough T1D, the Leading Global Type 1 Diabetes Research and Advocacy Organization, Expresses Gratitude for Extension of Special Diabetes Program
November 6, 2025
Breakthrough T1D Encouraged by Promising Results of FINE-ONE Phase 3 Clinical Trial Evaluating Finerenone for Chronic Kidney Disease Associated with Type 1 Diabetes
